134 related articles for article (PubMed ID: 31172693)
1. Breast cancer screening: Impact on care pathways.
Lefeuvre D; Catajar N; Le Bihan Benjamin C; Ifrah N; De Bels F; Viguier J; Bousquet PJ
Cancer Med; 2019 Jul; 8(8):4070-4078. PubMed ID: 31172693
[TBL] [Abstract][Full Text] [Related]
2. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Defossez G; Quillet A; Ingrand P
BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
[TBL] [Abstract][Full Text] [Related]
3. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
4. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
5. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study.
Lund E; Nakamura A; Thalabard JC
Eur J Cancer; 2018 Jan; 89():102-112. PubMed ID: 29245077
[TBL] [Abstract][Full Text] [Related]
6. French Medico-Administrative Data to Identify the Care Pathways of Women With Breast Cancer.
Lefeuvre D; Le Bihan-Benjamin C; Pauporté I; Medioni J; Bousquet PJ
Clin Breast Cancer; 2017 Jul; 17(4):e191-e197. PubMed ID: 28237608
[TBL] [Abstract][Full Text] [Related]
7. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
Hendrick RE
Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
[TBL] [Abstract][Full Text] [Related]
8. [Interest of individual breast cancer screening by mammography in women aged over 75 years].
Pelofi G; Martin X; Barben J; Jouanny P
Geriatr Psychol Neuropsychiatr Vieil; 2022 Jun; 20(2):182-189. PubMed ID: 35929385
[TBL] [Abstract][Full Text] [Related]
9. Benefits of Organized Mammographic Screening Programs in Women Aged 50 to 69 years: A Surgical Perspective.
Fancellu A; Sanna V; Sedda ML; Delrio D; Cottu P; Spanu A; Giuliani G; Conti M; Piras R; Crivelli P; Porcu A
Clin Breast Cancer; 2019 Oct; 19(5):e637-e642. PubMed ID: 31130366
[TBL] [Abstract][Full Text] [Related]
10. Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys.
Cutuli B; Dalenc F; Cottu PH; Gligorov J; Guastalla JP; Petit T; Amrate A
Cancer Radiother; 2015 Aug; 19(5):295-302. PubMed ID: 26188735
[TBL] [Abstract][Full Text] [Related]
11. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
12. Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario's experience.
Kumachev A; Trudeau ME; Chan KK
Cancer; 2016 Mar; 122(6):893-8. PubMed ID: 26696022
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer: The importance of overdiagnosis in breast-cancer screening.
Narod S
Nat Rev Clin Oncol; 2016 Jan; 13(1):5-6. PubMed ID: 26573419
[No Abstract] [Full Text] [Related]
14. Implications of Overdiagnosis: Impact on Screening Mammography Practices.
Morris E; Feig SA; Drexler M; Lehman C
Popul Health Manag; 2015 Sep; 18 Suppl 1(Suppl 1):S3-11. PubMed ID: 26414384
[TBL] [Abstract][Full Text] [Related]
15. The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer.
van Luijt PA; Rozemeijer K; Naber SK; Heijnsdijk EA; van Rosmalen J; van Ballegooijen M; de Koning HJ
J Med Screen; 2016 Dec; 23(4):210-216. PubMed ID: 27068430
[TBL] [Abstract][Full Text] [Related]
16. No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy.
Vapiwala N; Hwang WT; Kushner CJ; Schnall MD; Freedman GM; Solin LJ
Cancer; 2017 Apr; 123(8):1324-1332. PubMed ID: 27984658
[TBL] [Abstract][Full Text] [Related]
17. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.
Barth RJ; Gibson GR; Carney PA; Mott LA; Becher RD; Poplack SP
AJR Am J Roentgenol; 2005 Jan; 184(1):324-9. PubMed ID: 15615996
[TBL] [Abstract][Full Text] [Related]
18. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
